Literature DB >> 25946256

Glioblastoma multiforme in a child with tuberous sclerosis complex.

Aglaia Vignoli1, Elena Lesma2, Rosa Maria Alfano3, Angela Peron1, Giulia Federica Scornavacca1, Maura Massimino4, Elisabetta Schiavello4, Silvia Ancona2, Michele Cerati5, Gaetano Bulfamante3, Alfredo Gorio2, Maria Paola Canevini1.   

Abstract

Tuberous Sclerosis Complex (TSC) is characterized by the presence of benign tumors in the brain, kidneys, heart, eyes, lungs, and skin. The typical brain lesions are cortical tubers, subependimal nodules and subependymal giant-cell astrocytomas. The occurrence of malignant astrocytomas such as glioblastoma is rare. We report on a child with a clinical diagnosis of TSC and a rapidly evolving glioblastoma multiforme. Genetic analysis identified a de novo mutation in TSC2. Molecular characterization of the tumor was performed and discussed, as well as a review of the literature where cases of TSC and glioblastoma multiforme are described. Although the co-occurrence of TSC and glioblastoma multiforme seems to be rare, this possible association should be kept in mind, and proper clinical and radiological follow up should be recommended in these patients.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  Glioblastoma multiforme; TSC; Tuberous Sclerosis Complex; children; follow-up MR; tumors

Mesh:

Substances:

Year:  2015        PMID: 25946256     DOI: 10.1002/ajmg.a.37158

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  4 in total

1.  Calcitriol Reverses the Down-Regulation Pattern of Tuberous Sclerosis Complex Genes in an In Vitro Calcification Model.

Authors:  Eraldo Fonseca Dos Santos Junior; Roberta Rodrigues de Lemos Gitirana; Darlene Paiva Bezerra; João Ricardo Mendes de Oliveira
Journal:  J Mol Neurosci       Date:  2017-12-11       Impact factor: 3.444

2.  Stimulation of prolactin receptor induces STAT-5 phosphorylation and cellular invasion in glioblastoma multiforme.

Authors:  Amira Alkharusi; Shengze Yu; Natalia Landázuri; Fahad Zadjali; Belghis Davodi; Thomas Nyström; Torbjörn Gräslund; Afsar Rahbar; Gunnar Norstedt
Journal:  Oncotarget       Date:  2016-11-29

3.  Integration of genomics, high throughput drug screening, and personalized xenograft models as a novel precision medicine paradigm for high risk pediatric cancer.

Authors:  Maria Tsoli; Carol Wadham; Mark Pinese; Tim Failes; Swapna Joshi; Emily Mould; Julia X Yin; Velimir Gayevskiy; Amit Kumar; Warren Kaplan; Paul G Ekert; Federica Saletta; Laura Franshaw; Jie Liu; Andrew Gifford; Martin A Weber; Michael Rodriguez; Richard J Cohn; Greg Arndt; Vanessa Tyrrell; Michelle Haber; Toby Trahair; Glenn M Marshall; Kerrie McDonald; Mark J Cowley; David S Ziegler
Journal:  Cancer Biol Ther       Date:  2018-10-09       Impact factor: 4.742

4.  Long Noncoding RNA WT1-AS Inhibit Cell Malignancy via miR-494-3p in Glioma.

Authors:  Guangting Qiu; Wenjie Tong; Chenghao Jiang; Qingsong Xie; Jingfang Zou; Cong Luo; Jianwei Zhao; Lu Zhang; Jiang Zhao
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.